Skip to content

An AI-assisted system for endoscopic ultrasonography ofBile duct and pancreatic duct: a prospective validation experiment.

An AI-assisted system for endoscopic ultrasonography ofBile duct and pancreatic duct: a prospective validation experiment.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900028648
Enrollment
Unknown
Registered
2019-12-29
Start date
2020-01-01
Completion date
Unknown
Last updated
2020-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bile duct and pancreatic duct

Interventions

Gold Standard:Endoscopes doctor's diagnosis
system&#32
for&#32
ultrasonography

Sponsors

Remin Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. male or female aged 18 or above; 2. endoscopic ultrasonography and related examinations should be conducted to further clarify the characteristics of digestive tract diseases; 3. be able to read, understand and sign the informed consent; 4. the researcher believes that the subjects can understand the process of the clinical study, are willing and able to complete all the study procedures and follow-up visits, and cooperate with the study procedures.

Exclusion criteria

Exclusion criteria: 1. have participated in other clinical trials, signed the informed consent and have been in the follow-up period of other clinical trials; 2. drug or alcohol abuse or psychological disorder in the last 5 years; 3. pregnant or nursing women; 4. subjects with previous history of upper gastrointestinal surgery; 5. the researcher thinks that the subject is not suitable for endoscopic ultrasonography and related examinations; 6. high-risk diseases or other special conditions that the investigator considers inappropriate for the subject to participate in the clinical trial; 7. patients with anatomical abnormalities of the upper digestive tract caused by advanced tumors; 8. the presence of definite anatomical structures of the biliary and pancreatic ducts was not observed.

Design outcomes

Primary

MeasureTime frame
Accuracy of endoscopic ultrasonography in correctly segmentating the bile duct and pancreatic duct;

Secondary

MeasureTime frame
accuracy of measurement of biliary and pancreatic duct;the accurate of the segmentation area of biliary and pancreatic duct ;

Countries

China

Contacts

Public ContactHonggag Yu

Dapartment of Gastroenterology, Remin Hospital of Wuhan University

yuhonggang@163.com+86 13871281899

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026